| Document Date: 2014-10-17 03:49:19
Open Document File Size: 619,65 KBShare Result on Facebook
Country Australia / / / MedicalCondition annual infections / primary liver cancer / chronic disease / cancer / disease / hepatitis C. Compounding / hepatocellar carcinoma / strain / infection / liver failure / advanced liver disease / HCV infections / liver disease / infections / rash / chronic hepatitis C. Aboriginal / chronic hepatitis C / hepatitis C / HCV / / Organization Senate Community Affairs Reference Committee / Australian government / PBAC Secretariat / Pharmaceutical Benefit Advisory Committee / Pharmaceutical Benefits Advisory Committee for TELAPREVIR / / Person Torres Strait / Torres Strait Islander / C. Aboriginal / Carrie Fowlie / / / Position Executive Officer / / Product Ribavirin / / Technology genotype / / URL www.atoda.org.au / /
SocialTag |
ATODA Submission to PBAC Telaprevir Final 0212